Company research / LUNG
Pulmonx Corp (LUNG)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Pulmonx Corp reported revenue of $90.50M. Revenue grew 8.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $87.44M.
Key ratios (year ended 2025-12-31)
74.2%
Gross margin
-59.3%
Operating margin
-59.7%
Net margin
-99.8%
Return on year-end equity
8.0%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.